TerelNewton.com

I. Healthcare Industry Overview

Global value = $9.8 T (2023) → largest sector worldwide U.S. total = $4.5 T (2022) = 17.3 % GDP
Growth rate ≈ 5.5 % CAGR through 2030 Per-capita spend ≈ $13.5 K (2023) per American
Medicare spending ≈ $1 T (2023) federal coverage program Prescription drugs ≈ $405 B (2022) pharma expenditure only
AI in healthcare $20 B → $187 B by 2030 (+9× growth) Telehealth $120 B → $455 B by 2030 (+4× growth)
Workforce ≈ 21 M workers (~14 % of U.S. employment)

SPACE MEDICINE

II. Major U.S. Condition Costs

Chronic Pain $560–635 B / yr → #1 cost burden
Mental Health $280–320 B / yr → depression, anxiety, SUD
Diabetes $327 B (2022) → high treatment + productivity loss
Cardiovascular $407 B (2023) → projected $1 T by 2035
Cancer $208 B (2022) → $250 B by 2030
Arthritis/MSK $304 B (2023) → mobility & aging impact
Alzheimer’s $345 B (2024) → > $1 T by 2050
Obesity $260 B (2023) → lifestyle linked chronic costs
Substance Use $532 B (2023) → opioids, alcohol, others

III. Medical Cannabis Industry Overview

Global market $13.8 B (2022) → $211.5 B (2035) 13 % CAGR
U.S. sales $33.6 B (2023) → $13 B medical segment
Avg patients ≈ 5.5 M (2024) U.S. registered users
Spend/patient ≈ $2–3.5 K annually out-of-pocket
Main use = Chronic Pain (~26 % of patients)
Jobs ≈ 440 K FTE (2024) → fastest-growing sector
Top states = CA $5.1 B, MI $3.1 B, FL $2.2 B

IV. Comparative Ratios

Market size ratio ≈ 700 : 1 (health vs cannabis)
Growth rate 5 % vs 13–14 % (CAGR comparison)
Pain cost $600 B vs cannabis market $13 B (45×)
Spend/patient $13 K vs $2–3 K (6× difference)

Outline: Major Sectors of the U.S. Economy (2022–2023, GDP ≈ $26 T)
(Each line shows share of GDP and brief definition – major sectors only)

I. Healthcare & Social Assistance – ≈ 17 % GDP (~ $4.5 T) Hospitals, physicians, nursing, insurance, mental health, and public health services.

II. Finance & Insurance – ≈ 8 % GDP (~ $2.1 T)

Outline: Major Sectors of the U.S. Economy (2022–2023, GDP ≈ $26 T)
(Each line shows share of GDP and brief definition – major sectors only)

I. Healthcare & Social Assistance – ≈ 17 % GDP (~ $4.5 T) Hospitals, physicians, nursing, insurance, mental health, and public health services.

II. Finance & Insurance – ≈ 8 % GDP (~ $2.1 T) Banking, credit, investment, real estate finance, and insurance products.

III. Manufacturing – ≈ 11 % GDP (~ $2.9 T) Durable goods (automotive, aerospace, machinery) and nondurable goods (chemicals, food, pharma).

IV. Government (Federal + State + Local) – ≈ 12 % GDP (~ $3.1 T) Defense, education, infrastructure, public safety, and administration expenditures.

V. Professional & Business Services – ≈ 13 % GDP (~ $3.4 T) Legal, consulting, engineering, IT, management, and scientific services.

VI. Information Technology & Media – ≈ 6 % GDP (~ $1.6 T) Software, telecom, streaming, publishing, data centers, and cyber infrastructure.

VII. Retail & Wholesale Trade – ≈ 12 % GDP (~ $3.1 T) Consumer goods sales, e-commerce, and supply-chain distribution networks.

VIII. Construction & Real Estate – ≈ 13 % GDP (~ $3.4 T) Residential, commercial, and industrial building plus property management and leasing.

IX. Transportation & Warehousing – ≈ 3 % GDP (~ $780 B) Air, rail, trucking, shipping, and logistics operations.

X. Energy & Utilities – ≈ 3 % GDP (~ $780 B) Oil, gas, electric power, renewables, and water utilities.

XI. Education & Training Services – ≈ 6 % GDP (~ $1.6 T) Public and private schools, universities, vocational and online education.

XII. Agriculture, Forestry & Mining – ≈ 1.5 % GDP (~ $390 B) Farming, livestock, timber, and natural resource extraction.

XIII. Entertainment & Hospitality – ≈ 4 % GDP (~ $1.0 T) Tourism, restaurants, hotels, sports, and arts industries.

References

U.S. Bureau of Economic Analysis (BEA): GDP by Industry Data 2023.
https://www.bea.gov/data/gdp/gdp-industry
U.S. Department of Commerce: Industry Economic Accounts 2023.
https://apps.bea.gov/industry/gdpbyind-data.htm

PROJECTED ... 2035

A. Healthcare Industry (2035 Estimates)

Global healthcare ≈ $15–16 T (2035) – total worldwide medical expenditure including hospitals, drugs, and insurance systems.
U.S. healthcare ≈ $7–8 T (2035) – expected to reach 18–20% of national GDP due to aging and chronic illness.
Per-capita spend ≈ $20–22 K/person – average U.S. annual medical expense including insurance, medications, and services.
Medicare ≈ $1.8 T – federal coverage for elderly and disabled; major budget driver by 2035.
Prescription drugs ≈ $750–800 B – cost of branded, generic, and specialty medications; high due to new therapies.
AI in healthcare ≈ $500 B+ – automation of diagnostics, patient monitoring, predictive analytics, and administrative tasks.
Telehealth ≈ $900 B+ – virtual and hybrid patient visits, remote monitoring, and digital care expansion.
Healthcare workforce ≈ 27–30 M workers – roughly one in five U.S. jobs in health-related fields.

B. Medical Cannabis Industry (2035 Estimates)

Global market ≈ $211.5 B – includes cultivation, medical products, clinical sales, and pharma-grade cannabinoids.
U.S. market ≈ $80–90 B total – combined medical and recreational sectors after further legalization and access growth.
Medical-only segment ≈ $35–40 B – regulated therapeutic cannabis for qualifying conditions under physician supervision.
Registered patients ≈ 12–15 M – twice 2024 levels as more states legalize and physicians adopt use.
Avg spend/patient ≈ $3.5–4.5 K/year – cash-based expenditures for prescriptions, dispensary purchases, and follow-ups.
Chronic pain users ≈ 30–35% of total – dominant therapeutic group; represents most consistent medical use case.
Employment ≈ 900 K–1.1 M jobs – growers, dispensary staff, clinicians, and supply-chain roles in cannabis sector.
Top states (est.) CA $10 B, FL $5 B, MI $4 B, IL $3 B, NY $3 B – largest contributors driven by mature markets and patient volume.

C. Comparative Snapshot (2035)

Healthcare : Cannabis = ≈180 : 1 (global) – medical sector vastly larger but cannabis growing faster percentage-wise.
CAGR 2024–2035 = 5% vs 13–14% – medical cannabis expanding 2–3× faster than general healthcare.
Pain costs ($600 B/yr) >15× cannabis market – chronic pain remains far costlier than total cannabis revenue.
Avg spend/patient: $20–22 K vs $4 K – traditional healthcare much higher due to hospital, drug, and insurance costs.
Employment: 30 M vs 1 M – healthcare remains dominant employer; cannabis emerging as fastest-growing niche sector.

PROJECTED WORKFORCE... 2035

Breakdown: U.S. Healthcare Workforce Composition (≈ 27–30 Million Workers by 2035)
(Each line includes % of total + 6–12 word explanation for clarity)

I. Overall Share

Total healthcare workforce ≈ 27–30 M (≈ 18–20 % of U.S. jobs) – one in five Americans employed in health, aging-care, or wellness sectors.

II. Employment by Major Category

Hospitals – 32 % (~9 M) – physicians, nurses, techs, administrators, and support staff in acute care facilities.
Ambulatory/Outpatient Services – 26 % (~7.5 M) – clinics, surgical centers, therapy offices, urgent care, telehealth providers.
Nursing & Residential Care – 14 % (~4 M) – long-term care, rehab, assisted living, home health aides, and CNA roles.
Physicians & Surgeons – 4 % (~1.2 M) – MD/DO professionals across specialties; highest earning subset.
Registered Nurses (RNs) – 9 % (~2.6 M) – largest licensed clinical group; direct patient care in multiple settings.
Technologists & Technicians – 5 % (~1.4 M) – imaging, lab, pharmacy, surgical, and respiratory technologists.
Mental & Behavioral Health – 3 % (~900 K) – psychologists, therapists, social workers, substance-use specialists.
Public Health & Administration – 4 % (~1.1 M) – health departments, policy staff, managers, billing and compliance officers.
Dental Care – 2 % (~600 K) – dentists, hygienists, assistants serving preventive and restorative needs.
Pharmaceutical & Biotech Manufacturing – 3 % (~800 K) – R&D, production, and distribution of therapeutics and vaccines.

III. Support & Emerging Roles

Home Health & Personal Care Aides – 7 % (~2 M) – fastest-growing segment; aging population drives demand for home care.
AI & Health Tech Specialists – 1 % (~300 K) – developers, data scientists, AI trainers in digital health systems.
Administrative Support – 8 % (~2.3 M) – billing, records, coding, compliance, and office coordination functions.

IV. Key Takeaways

Clinicians (physicians + nurses + therapists) ≈ 45 % of healthcare jobs.
Support & administrative ≈ 30 % — essential for billing and regulatory compliance.
Tech and AI roles expected to exceed 2 % by 2035.
Home care and aging services grow fastest (+25 % projected 2030→2035).

U.S. Cannabis Industry Workforce (2024 Est)

Total ≈ 425,000 – 440,000 full-time-equivalent (FTE) jobs | Percent by sector:

Cultivation: ≈ 31 % — grow operations, nurseries, trimming, and post-harvest processing
Retail (Dispensaries): ≈ 23 % — budtenders, store managers, inventory staff
Ancillary / Non-plant-touching: ≈ 20 % — software, marketing, HR, security, consulting\

Processing / Manufacturing: ≈ 17 % — extraction, edible production, packaging lines
Wholesale: ≈ 7 % — B2B product distribution and supply logistics
Distribution / Delivery: ≈ 2 % — drivers, warehouse coordinators, last-mile delivery
esting Laboratories: < 1 % — quality assurance and compliance testing roles

Share of total U.S. employment: ≈ 0.25 – 0.30 % of the national workforce (about 160 million jobs).

Primary References

Vangst (2024). Vangst 2024 Jobs Report.
PDF download: https://5711383.fs1.hubspotusercontent-na1.net/hubfs/5711383/VangstJobsReport2024-WEB-FINALFINAL.pdf
Landing page: https://www.vangst.com/2024-jobs-report
Cannabis Business Times (2024). U.S. Cannabis Industry Revenue Grows to $30 B, Jobs Stall at 425,000.
https://www.cannabisbusinesstimes.com/industry-headlines/news/15745739/us-cannabis-industry-revenue-grows-to-30b-jobs-stall-at-425000

U.S. Cannabis Industry Workforce Breakdown (2024 Estimates)

Total employment: ≈ 425,000 – 440,000 full-time-equivalent (FTE) jobs
Percent by sector:

Cultivation: ≈ 31 % — grow operations, nurseries, trimming, and post-harvest processing
Retail (Dispensaries): ≈ 23 % — budtenders, store managers, inventory staff
Processing / Manufacturing: ≈ 17 % — extraction, edible production, packaging lines
Wholesale: ≈ 7 % — B2B product distribution and supply logistics
Distribution / Delivery: ≈ 2 % — drivers, warehouse coordinators, last-mile delivery
Testing Laboratories: < 1 % — quality assurance and compliance testing roles
Ancillary / Non-plant-touching: ≈ 20 % — software, marketing, HR, security, consulting

Share of total U.S. employment: ≈ 0.25 – 0.30 % of the national workforce (about 160 million jobs).

Primary References

Vangst (2024). Vangst 2024 Jobs Report.
PDF download: https://5711383.fs1.hubspotusercontent-na1.net/hubfs/5711383/VangstJobsReport2024-WEB-FINALFINAL.pdf
Landing page: https://www.vangst.com/2024-jobs-report
Cannabis Business Times (2024). U.S. Cannabis Industry Revenue Grows to $30 B, Jobs Stall at 425,000.
https://www.cannabisbusinesstimes.com/industry-headlines/news/15745739/us-cannabis-industry-revenue-grows-to-30b-jobs-stall-at-425000

A. Healthcare Industry (2035 Estimates)

Global healthcare ≈ $15–16 T (2035) – total worldwide medical expenditure including hospitals, drugs, and insurance systems.
U.S. healthcare ≈ $7–8 T (2035) – expected to reach 18–20% of national GDP due to aging and chronic illness.
Per-capita spend ≈ $20–22 K/person – average U.S. annual medical expense including insurance, medications, and services.
Medicare ≈ $1.8 T – federal coverage for elderly and disabled; major budget driver by 2035.
Prescription drugs ≈ $750–800 B – cost of branded, generic, and specialty medications; high due to new therapies.
AI in healthcare ≈ $500 B+ – automation of diagnostics, patient monitoring, predictive analytics, and administrative tasks.
Telehealth ≈ $900 B+ – virtual and hybrid patient visits, remote monitoring, and digital care expansion.
Healthcare workforce ≈ 27–30 M workers – roughly one in five U.S. jobs in health-related fields.

B. Medical Cannabis Industry (2035 Estimates)

Global market ≈ $211.5 B – includes cultivation, medical products, clinical sales, and pharma-grade cannabinoids.
U.S. market ≈ $80–90 B total – combined medical and recreational sectors after further legalization and access growth.
Medical-only segment ≈ $35–40 B – regulated therapeutic cannabis for qualifying conditions under physician supervision.
Registered patients ≈ 12–15 M – twice 2024 levels as more states legalize and physicians adopt use.
Avg spend/patient ≈ $3.5–4.5 K/year – cash-based expenditures for prescriptions, dispensary purchases, and follow-ups.
Chronic pain users ≈ 30–35% of total – dominant therapeutic group; represents most consistent medical use case.
Employment ≈ 900 K–1.1 M jobs – growers, dispensary staff, clinicians, and supply-chain roles in cannabis sector.
Top states (est.) CA $10 B, FL $5 B, MI $4 B, IL $3 B, NY $3 B – largest contributors driven by mature markets and patient volume.

C. Comparative Snapshot (2035)

Healthcare : Cannabis = ≈180 : 1 (global) – medical sector vastly larger but cannabis growing faster percentage-wise.
CAGR 2024–2035 = 5% vs 13–14% – medical cannabis expanding 2–3× faster than general healthcare.
Pain costs ($600 B/yr) >15× cannabis market – chronic pain remains far costlier than total cannabis revenue.
Avg spend/patient: $20–22 K vs $4 K – traditional healthcare much higher due to hospital, drug, and insurance costs.
Employment: 30 M vs 1 M – healthcare remains dominant employer; cannabis emerging as fastest-growing niche sector.

Page updated

Google Sites

Report abuse

I. Healthcare Industry Overview

II. Major U.S. Condition Costs

III. Medical Cannabis Industry Overview

IV. Comparative Ratios

I. Healthcare & Social Assistance – ≈ 17 % GDP (~ $4.5 T) Hospitals, physicians, nursing, insurance, mental health, and public health services.

II. Finance & Insurance – ≈ 8 % GDP (~ $2.1 T)

I. Healthcare & Social Assistance – ≈ 17 % GDP (~ $4.5 T) Hospitals, physicians, nursing, insurance, mental health, and public health services.

II. Finance & Insurance – ≈ 8 % GDP (~ $2.1 T) Banking, credit, investment, real estate finance, and insurance products.

III. Manufacturing – ≈ 11 % GDP (~ $2.9 T) Durable goods (automotive, aerospace, machinery) and nondurable goods (chemicals, food, pharma).

IV. Government (Federal + State + Local) – ≈ 12 % GDP (~ $3.1 T) Defense, education, infrastructure, public safety, and administration expenditures.

V. Professional & Business Services – ≈ 13 % GDP (~ $3.4 T) Legal, consulting, engineering, IT, management, and scientific services.

VI. Information Technology & Media – ≈ 6 % GDP (~ $1.6 T) Software, telecom, streaming, publishing, data centers, and cyber infrastructure.

VII. Retail & Wholesale Trade – ≈ 12 % GDP (~ $3.1 T) Consumer goods sales, e-commerce, and supply-chain distribution networks.

VIII. Construction & Real Estate – ≈ 13 % GDP (~ $3.4 T) Residential, commercial, and industrial building plus property management and leasing.

IX. Transportation & Warehousing – ≈ 3 % GDP (~ $780 B) Air, rail, trucking, shipping, and logistics operations.

X. Energy & Utilities – ≈ 3 % GDP (~ $780 B) Oil, gas, electric power, renewables, and water utilities.

XI. Education & Training Services – ≈ 6 % GDP (~ $1.6 T) Public and private schools, universities, vocational and online education.

XII. Agriculture, Forestry & Mining – ≈ 1.5 % GDP (~ $390 B) Farming, livestock, timber, and natural resource extraction.

XIII. Entertainment & Hospitality – ≈ 4 % GDP (~ $1.0 T) Tourism, restaurants, hotels, sports, and arts industries.

References

PROJECTED ... 2035

A. Healthcare Industry (2035 Estimates)

B. Medical Cannabis Industry (2035 Estimates)

C. Comparative Snapshot (2035)

PROJECTED WORKFORCE... 2035

I. Overall Share

II. Employment by Major Category

III. Support & Emerging Roles

IV. Key Takeaways

U.S. Cannabis Industry Workforce (2024 Est)

Total ≈ 425,000 – 440,000 full-time-equivalent (FTE) jobs | Percent by sector:

Cultivation: ≈ 31 % — grow operations, nurseries, trimming, and post-harvest processingRetail (Dispensaries): ≈ 23 % — budtenders, store managers, inventory staffAncillary / Non-plant-touching: ≈ 20 % — software, marketing, HR, security, consulting\

Primary References

U.S. Cannabis Industry Workforce Breakdown (2024 Estimates)

Primary References

A. Healthcare Industry (2035 Estimates)

B. Medical Cannabis Industry (2035 Estimates)

C. Comparative Snapshot (2035)

Cultivation: ≈ 31 % — grow operations, nurseries, trimming, and post-harvest processing
Retail (Dispensaries): ≈ 23 % — budtenders, store managers, inventory staff
Ancillary / Non-plant-touching: ≈ 20 % — software, marketing, HR, security, consulting\